Close

Ratings by Credit Suisse (Richard Law)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/8/2022 Arvinas Inc. ARVN Maintain Outperform
(N/A)
 
 
  Details
11/7/2022 Beam Therapeutics Inc BEAM Maintain Neutral
(N/A)
 
 
  Details
11/4/2022 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
11/3/2022 Kymera Therapeutics KYMR Maintain Outperform
(N/A)
 
 
  Details
11/2/2022 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
10/6/2022 Verve Therapeutics VERV New Coverage Neutral
(N/A)
36.15
(21.74)
-39.86% Details
8/16/2022 Homology Medicines FIXX Maintain Neutral
(N/A)
 
 
  Details
8/8/2022 CRISPR Therapeutics CRSP Maintain Neutral
(N/A)
 
 
  Details
6/13/2022 Homology Medicines FIXX Maintain Neutral
(N/A)
 
 
  Details
5/17/2022 Homology Medicines FIXX Maintain Neutral
(N/A)
 
 
  Details
4/28/2022 Beam Therapeutics Inc BEAM New Coverage Neutral
(N/A)
39.83
(43.61)
9.49% Details
4/28/2022 CRISPR Therapeutics CRSP New Coverage Neutral
(N/A)
51.96
(52.88)
1.77% Details